Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis
Titel:
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis
Auteur:
Kubota, K. Ichinose, Y. Scagliotti, G. Spigel, D. Kim, J.H. Shinkai, T. Takeda, K. Kim, S.-W. Hsia, T.-C. Li, R.K. Tiangco, B.J. Yau, S. Lim, W.-T. Yao, B. Hei, Y.-J. Park, K.